Global Diabetes Drug Therapy Market Size, Status and Forecast 2020-2026

May 2020 | 97 pages | ID: GC2730E7EDCEEN
QYResearch

Abstracts

This report focuses on the global Diabetes Drug Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetes Drug Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Abbott Laboratories
• Mannkind Corporation
• Bristol Myers Squibb
• Medtronic
• AstraZeneca
• Eli Lilly and Company
• GlaxoSmithKline
• Sanofi
• Novo Nordisk
• Novartis International AG

Market segment by Type, the product can be split into

• Glucagon-likepeptide-1 (GLP-1)agonist
• Dipeptidyl-peptidase-4 (DPP-4)inhibitors
• Sodium glucoseco-transporter 2 (SGLT2)inhibitors
• Insulin
• Others

Market segment by Application, split into

• Type1 Diabetes
• Type2 Diabetes
• GestationalDiabetes
• ImpairedGlucoseToleranceandImpairedFasting Glycaemia

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Diabetes Drug Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Diabetes Drug Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Diabetes Drug Therapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetes Drug Therapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Diabetes Drug Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Glucagon-likepeptide-1 (GLP-1)agonist
  1.4.3 Dipeptidyl-peptidase-4 (DPP-4)inhibitors
  1.4.4 Sodium glucoseco-transporter 2 (SGLT2)inhibitors
  1.4.5 Insulin
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Diabetes Drug Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Type1 Diabetes
  1.5.3 Type2 Diabetes
  1.5.4 GestationalDiabetes
  1.5.5 ImpairedGlucoseToleranceandImpairedFasting Glycaemia
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Diabetes Drug Therapy Market Perspective (2015-2026)
2.2 Diabetes Drug Therapy Growth Trends by Regions
  2.2.1 Diabetes Drug Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Diabetes Drug Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Diabetes Drug Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Diabetes Drug Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Diabetes Drug Therapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Diabetes Drug Therapy Players by Market Size
  3.1.1 Global Top Diabetes Drug Therapy Players by Revenue (2015-2020)
  3.1.2 Global Diabetes Drug Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Diabetes Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetes Drug Therapy Market Concentration Ratio
  3.2.1 Global Diabetes Drug Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Diabetes Drug Therapy Revenue in 2019
3.3 Diabetes Drug Therapy Key Players Head office and Area Served
3.4 Key Players Diabetes Drug Therapy Product Solution and Service
3.5 Date of Enter into Diabetes Drug Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Diabetes Drug Therapy Historic Market Size by Type (2015-2020)
4.2 Global Diabetes Drug Therapy Forecasted Market Size by Type (2021-2026)

5 DIABETES DRUG THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Diabetes Drug Therapy Market Size by Application (2015-2020)
5.2 Global Diabetes Drug Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Diabetes Drug Therapy Market Size (2015-2020)
6.2 Diabetes Drug Therapy Key Players in North America (2019-2020)
6.3 North America Diabetes Drug Therapy Market Size by Type (2015-2020)
6.4 North America Diabetes Drug Therapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Diabetes Drug Therapy Market Size (2015-2020)
7.2 Diabetes Drug Therapy Key Players in Europe (2019-2020)
7.3 Europe Diabetes Drug Therapy Market Size by Type (2015-2020)
7.4 Europe Diabetes Drug Therapy Market Size by Application (2015-2020)

8 CHINA

8.1 China Diabetes Drug Therapy Market Size (2015-2020)
8.2 Diabetes Drug Therapy Key Players in China (2019-2020)
8.3 China Diabetes Drug Therapy Market Size by Type (2015-2020)
8.4 China Diabetes Drug Therapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Diabetes Drug Therapy Market Size (2015-2020)
9.2 Diabetes Drug Therapy Key Players in Japan (2019-2020)
9.3 Japan Diabetes Drug Therapy Market Size by Type (2015-2020)
9.4 Japan Diabetes Drug Therapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Diabetes Drug Therapy Market Size (2015-2020)
10.2 Diabetes Drug Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetes Drug Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetes Drug Therapy Market Size by Application (2015-2020)

11 INDIA

11.1 India Diabetes Drug Therapy Market Size (2015-2020)
11.2 Diabetes Drug Therapy Key Players in India (2019-2020)
11.3 India Diabetes Drug Therapy Market Size by Type (2015-2020)
11.4 India Diabetes Drug Therapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Diabetes Drug Therapy Market Size (2015-2020)
12.2 Diabetes Drug Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetes Drug Therapy Market Size by Type (2015-2020)
12.4 Central & South America Diabetes Drug Therapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Details
  13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.1.3 Abbott Laboratories Diabetes Drug Therapy Introduction
  13.1.4 Abbott Laboratories Revenue in Diabetes Drug Therapy Business (2015-2020))
  13.1.5 Abbott Laboratories Recent Development
13.2 Mannkind Corporation
  13.2.1 Mannkind Corporation Company Details
  13.2.2 Mannkind Corporation Business Overview and Its Total Revenue
  13.2.3 Mannkind Corporation Diabetes Drug Therapy Introduction
  13.2.4 Mannkind Corporation Revenue in Diabetes Drug Therapy Business (2015-2020)
  13.2.5 Mannkind Corporation Recent Development
13.3 Bristol Myers Squibb
  13.3.1 Bristol Myers Squibb Company Details
  13.3.2 Bristol Myers Squibb Business Overview and Its Total Revenue
  13.3.3 Bristol Myers Squibb Diabetes Drug Therapy Introduction
  13.3.4 Bristol Myers Squibb Revenue in Diabetes Drug Therapy Business (2015-2020)
  13.3.5 Bristol Myers Squibb Recent Development
13.4 Medtronic
  13.4.1 Medtronic Company Details
  13.4.2 Medtronic Business Overview and Its Total Revenue
  13.4.3 Medtronic Diabetes Drug Therapy Introduction
  13.4.4 Medtronic Revenue in Diabetes Drug Therapy Business (2015-2020)
  13.4.5 Medtronic Recent Development
13.5 AstraZeneca
  13.5.1 AstraZeneca Company Details
  13.5.2 AstraZeneca Business Overview and Its Total Revenue
  13.5.3 AstraZeneca Diabetes Drug Therapy Introduction
  13.5.4 AstraZeneca Revenue in Diabetes Drug Therapy Business (2015-2020)
  13.5.5 AstraZeneca Recent Development
13.6 Eli Lilly and Company
  13.6.1 Eli Lilly and Company Company Details
  13.6.2 Eli Lilly and Company Business Overview and Its Total Revenue
  13.6.3 Eli Lilly and Company Diabetes Drug Therapy Introduction
  13.6.4 Eli Lilly and Company Revenue in Diabetes Drug Therapy Business (2015-2020)
  13.6.5 Eli Lilly and Company Recent Development
13.7 GlaxoSmithKline
  13.7.1 GlaxoSmithKline Company Details
  13.7.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.7.3 GlaxoSmithKline Diabetes Drug Therapy Introduction
  13.7.4 GlaxoSmithKline Revenue in Diabetes Drug Therapy Business (2015-2020)
  13.7.5 GlaxoSmithKline Recent Development
13.8 Sanofi
  13.8.1 Sanofi Company Details
  13.8.2 Sanofi Business Overview and Its Total Revenue
  13.8.3 Sanofi Diabetes Drug Therapy Introduction
  13.8.4 Sanofi Revenue in Diabetes Drug Therapy Business (2015-2020)
  13.8.5 Sanofi Recent Development
13.9 Novo Nordisk
  13.9.1 Novo Nordisk Company Details
  13.9.2 Novo Nordisk Business Overview and Its Total Revenue
  13.9.3 Novo Nordisk Diabetes Drug Therapy Introduction
  13.9.4 Novo Nordisk Revenue in Diabetes Drug Therapy Business (2015-2020)
  13.9.5 Novo Nordisk Recent Development
13.10 Novartis International AG
  13.10.1 Novartis International AG Company Details
  13.10.2 Novartis International AG Business Overview and Its Total Revenue
  13.10.3 Novartis International AG Diabetes Drug Therapy Introduction
  13.10.4 Novartis International AG Revenue in Diabetes Drug Therapy Business (2015-2020)
  13.10.5 Novartis International AG Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Diabetes Drug Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetes Drug Therapy Revenue
Table 3. Ranking of Global Top Diabetes Drug Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetes Drug Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Glucagon-likepeptide-1 (GLP-1)agonist
Table 6. Key Players of Dipeptidyl-peptidase-4 (DPP-4)inhibitors
Table 7. Key Players of Sodium glucoseco-transporter 2 (SGLT2)inhibitors
Table 8. Key Players of Insulin
Table 9. Key Players of Others
Table 10. Global Diabetes Drug Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Diabetes Drug Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Diabetes Drug Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Diabetes Drug Therapy Market Share by Regions (2015-2020)
Table 14. Global Diabetes Drug Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Diabetes Drug Therapy Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Diabetes Drug Therapy Market Growth Strategy
Table 20. Main Points Interviewed from Key Diabetes Drug Therapy Players
Table 21. Global Diabetes Drug Therapy Revenue by Players (2015-2020) (Million US$)
Table 22. Global Diabetes Drug Therapy Market Share by Players (2015-2020)
Table 23. Global Top Diabetes Drug Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Drug Therapy as of 2019)
Table 24. Global Diabetes Drug Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Diabetes Drug Therapy Product Solution and Service
Table 27. Date of Enter into Diabetes Drug Therapy Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$)
Table 30. Global Diabetes Drug Therapy Market Size Share by Type (2015-2020)
Table 31. Global Diabetes Drug Therapy Revenue Market Share by Type (2021-2026)
Table 32. Global Diabetes Drug Therapy Market Size Share by Application (2015-2020)
Table 33. Global Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$)
Table 34. Global Diabetes Drug Therapy Market Size Share by Application (2021-2026)
Table 35. North America Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Diabetes Drug Therapy Market Share (2019-2020)
Table 37. North America Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$)
Table 38. North America Diabetes Drug Therapy Market Share by Type (2015-2020)
Table 39. North America Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$)
Table 40. North America Diabetes Drug Therapy Market Share by Application (2015-2020)
Table 41. Europe Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Diabetes Drug Therapy Market Share (2019-2020)
Table 43. Europe Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Diabetes Drug Therapy Market Share by Type (2015-2020)
Table 45. Europe Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Diabetes Drug Therapy Market Share by Application (2015-2020)
Table 47. China Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$)
Table 48. China Key Players Diabetes Drug Therapy Market Share (2019-2020)
Table 49. China Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$)
Table 50. China Diabetes Drug Therapy Market Share by Type (2015-2020)
Table 51. China Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$)
Table 52. China Diabetes Drug Therapy Market Share by Application (2015-2020)
Table 53. Japan Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Diabetes Drug Therapy Market Share (2019-2020)
Table 55. Japan Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Diabetes Drug Therapy Market Share by Type (2015-2020)
Table 57. Japan Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Diabetes Drug Therapy Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Diabetes Drug Therapy Market Share (2019-2020)
Table 61. Southeast Asia Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Diabetes Drug Therapy Market Share by Type (2015-2020)
Table 63. Southeast Asia Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Diabetes Drug Therapy Market Share by Application (2015-2020)
Table 65. India Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$)
Table 66. India Key Players Diabetes Drug Therapy Market Share (2019-2020)
Table 67. India Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$)
Table 68. India Diabetes Drug Therapy Market Share by Type (2015-2020)
Table 69. India Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$)
Table 70. India Diabetes Drug Therapy Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Diabetes Drug Therapy Market Share (2019-2020)
Table 73. Central & South America Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Diabetes Drug Therapy Market Share by Type (2015-2020)
Table 75. Central & South America Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Diabetes Drug Therapy Market Share by Application (2015-2020)
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Product
Table 80. Abbott Laboratories Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$)
Table 81. Abbott Laboratories Recent Development
Table 82. Mannkind Corporation Company Details
Table 83. Mannkind Corporation Business Overview
Table 84. Mannkind Corporation Product
Table 85. Mannkind Corporation Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$)
Table 86. Mannkind Corporation Recent Development
Table 87. Bristol Myers Squibb Company Details
Table 88. Bristol Myers Squibb Business Overview
Table 89. Bristol Myers Squibb Product
Table 90. Bristol Myers Squibb Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$)
Table 91. Bristol Myers Squibb Recent Development
Table 92. Medtronic Company Details
Table 93. Medtronic Business Overview
Table 94. Medtronic Product
Table 95. Medtronic Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$)
Table 96. Medtronic Recent Development
Table 97. AstraZeneca Company Details
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Product
Table 100. AstraZeneca Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$)
Table 101. AstraZeneca Recent Development
Table 102. Eli Lilly and Company Company Details
Table 103. Eli Lilly and Company Business Overview
Table 104. Eli Lilly and Company Product
Table 105. Eli Lilly and Company Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$)
Table 106. Eli Lilly and Company Recent Development
Table 107. GlaxoSmithKline Company Details
Table 108. GlaxoSmithKline Business Overview
Table 109. GlaxoSmithKline Product
Table 110. GlaxoSmithKline Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$)
Table 111. GlaxoSmithKline Recent Development
Table 112. Sanofi Business Overview
Table 113. Sanofi Product
Table 114. Sanofi Company Details
Table 115. Sanofi Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$)
Table 116. Sanofi Recent Development
Table 117. Novo Nordisk Company Details
Table 118. Novo Nordisk Business Overview
Table 119. Novo Nordisk Product
Table 120. Novo Nordisk Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$)
Table 121. Novo Nordisk Recent Development
Table 122. Novartis International AG Company Details
Table 123. Novartis International AG Business Overview
Table 124. Novartis International AG Product
Table 125. Novartis International AG Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$)
Table 126. Novartis International AG Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Diabetes Drug Therapy Market Share by Type: 2020 VS 2026
Figure 2. Glucagon-likepeptide-1 (GLP-1)agonist Features
Figure 3. Dipeptidyl-peptidase-4 (DPP-4)inhibitors Features
Figure 4. Sodium glucoseco-transporter 2 (SGLT2)inhibitors Features
Figure 5. Insulin Features
Figure 6. Others Features
Figure 7. Global Diabetes Drug Therapy Market Share by Application: 2020 VS 2026
Figure 8. Type1 Diabetes Case Studies
Figure 9. Type2 Diabetes Case Studies
Figure 10. GestationalDiabetes Case Studies
Figure 11. ImpairedGlucoseToleranceandImpairedFasting Glycaemia Case Studies
Figure 12. Diabetes Drug Therapy Report Years Considered
Figure 13. Global Diabetes Drug Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Diabetes Drug Therapy Market Share by Regions: 2020 VS 2026
Figure 15. Global Diabetes Drug Therapy Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Diabetes Drug Therapy Market Share by Players in 2019
Figure 18. Global Top Diabetes Drug Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Drug Therapy as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Diabetes Drug Therapy Revenue in 2019
Figure 20. North America Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Abbott Laboratories Revenue Growth Rate in Diabetes Drug Therapy Business (2015-2020)
Figure 29. Mannkind Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Mannkind Corporation Revenue Growth Rate in Diabetes Drug Therapy Business (2015-2020)
Figure 31. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Bristol Myers Squibb Revenue Growth Rate in Diabetes Drug Therapy Business (2015-2020)
Figure 33. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Medtronic Revenue Growth Rate in Diabetes Drug Therapy Business (2015-2020)
Figure 35. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AstraZeneca Revenue Growth Rate in Diabetes Drug Therapy Business (2015-2020)
Figure 37. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Eli Lilly and Company Revenue Growth Rate in Diabetes Drug Therapy Business (2015-2020)
Figure 39. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GlaxoSmithKline Revenue Growth Rate in Diabetes Drug Therapy Business (2015-2020)
Figure 41. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Sanofi Revenue Growth Rate in Diabetes Drug Therapy Business (2015-2020)
Figure 43. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Novo Nordisk Revenue Growth Rate in Diabetes Drug Therapy Business (2015-2020)
Figure 45. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Novartis International AG Revenue Growth Rate in Diabetes Drug Therapy Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed